US Patent Term Extension – Protecting Innovation Beyond the 20-Year Limit


 

In high-investment industries like pharma and biotech, years can be lost waiting for regulatory approvals. The US Patent Term Extension (PTE) offers a lifeline—recovering that time and extending market exclusivity.

Why it matters now:

  • Recover lost years: Add up to 5 years to a patent term.

  • Fair protection: Ensures at least 14 years of exclusivity post-approval.

  • Life sciences edge: Covers drugs, biologics, and medical devices hit hardest by FDA review delays.

  • Critical ROI: Every extra day of exclusivity can mean millions in revenue.

Compared to PTA (delays during prosecution) or SPCs (Europe), PTE is uniquely tailored to regulatory hurdles in the US—making it an essential strategy for innovators navigating FDA timelines.

💡 Stay ahead in patent strategy—read the full blog to explore how PTE safeguards your IP investment.
👉 US Patent Term Adjustments - Extending Patent Life Through Strategic Prosecution - PatSeer



Comments

Post a Comment

Popular posts from this blog

Free and Paid Patent Databases You Need to Know in 2026

Image
  Patent databases are no  longer  legal tools. In 2026, they have become  strategic intelligence systems  used by inventors, startups, R&D teams, IP professionals, and investors to understand where technology is headed and who is shaping the future.   With millions of active patents worldwide and over 4.5 million new applications filed every year, patent data now  represents  one of the largest structured sources of technical knowledge. But navigating this volume manually is impossible. The quality of your insights depends entirely on the database you use.   Free vs Paid Patent Databases: The Real Difference   Free patent databases are a great starting point. They work well for:    - Early-stage idea validation    - Academic learning    - Basic prior-art exploration   However, they are limited when it comes to  global coverage, legal-status depth, analytics, and AI-driven discovery .   Pa...
Read more

Quantum Computing Leadership Through the Lens of Patents

Image
  Quantum computing is moving rapidly from research labs to real-world commercialization. Governments and technology leaders are investing billions to secure leadership in a field that could reshape cybersecurity, drug discovery,  materials science, and national defense.   But market announcements only tell part of the story.  Patent data reveals where  true  competitive advantage is forming.   Patent filings in quantum computing surged after 2015, tracking the rise of cloud-accessible NISQ systems and national initiatives across the US, Europe, and China. While companies like IBM, Google, Microsoft, and Amazon hold large portfolios, emerging players such as Alibaba and D-Wave stand out for patent quality and strategic focus rather than sheer volume.   Geographically, the US and China dominate global protection strategies, with Europe close behind and markets like India, Australia, and Canada gaining momentum. The signal is clear: the quantum race...
Read more

Why Patent Search Is Moving Beyond Keywords

Image
  Boolean search has long been the foundation of patent research. Its strength lies in structure, control, and transparency. But today’s innovation landscape has outgrown it. Patent volumes are  massive;  technologies intersect across domains, and terminology changes faster than search strings can keep up.   Keyword-based searching assumes you already know how an invention will be described.  Relevant  patents are often buried behind alternate wording, new jargon, or unfamiliar phrasing. Even well-constructed Boolean queries struggle to balance precision and recall at scale.   AI Search takes a fundamentally different approach. Instead of matching exact terms, it analyzes context and intent. By understanding how concepts relate, AI can surface patents that are relevant in meaning, even when the language differs. Results are ranked by conceptual relevance, not just keyword overlap.   This shift delivers practical benefits: faster discovery, broader...
Read more